These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 15774441)
21. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Rossetti AO; Logroscino G; Bromfield EB Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542 [TBL] [Abstract][Full Text] [Related]
22. Super-refractory status epilepticus in West China. Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275 [TBL] [Abstract][Full Text] [Related]
23. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus. Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604 [TBL] [Abstract][Full Text] [Related]
24. Early predictors of refractory status epilepticus: an international two-center study. Sutter R; Kaplan PW; Marsch S; Hammel EM; Rüegg S; Ziai WC Eur J Neurol; 2015 Jan; 22(1):79-85. PubMed ID: 25104078 [TBL] [Abstract][Full Text] [Related]
25. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331 [TBL] [Abstract][Full Text] [Related]
26. Predictors of outcomes and refractoriness in status epilepticus: A prospective study. Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335 [TBL] [Abstract][Full Text] [Related]
27. The Clinical Characteristics and Prognostic Analysis of Status Epilepticus in Northeast China. Sun L; Han C; Lin W Eur Neurol; 2017; 78(5-6):234-239. PubMed ID: 28942441 [TBL] [Abstract][Full Text] [Related]
28. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience. Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405 [TBL] [Abstract][Full Text] [Related]
29. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. Hottinger A; Sutter R; Marsch S; Rüegg S CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481 [TBL] [Abstract][Full Text] [Related]
30. Status epilepticus associated with acute encephalitis: long-term follow-up of functional and cognitive outcomes in 72 patients. Chen W; Su Y; Jiang M; Liu G; Tian F; Ren G Eur J Neurol; 2018 Oct; 25(10):1228-1234. PubMed ID: 29751371 [TBL] [Abstract][Full Text] [Related]
31. Status epilepticus: Refractory and super-refractory. Dubey D; Kalita J; Misra UK Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491 [TBL] [Abstract][Full Text] [Related]
32. Very high dose phenobarbital for refractory status epilepticus. Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708 [TBL] [Abstract][Full Text] [Related]
33. [Refractory status epilepticus in children: characterisation of epilepsies, continuous electroencephalographic monitoring and response to treatment]. Cardoso I; Acevedo K; Hernández M; Santin J; Moya P; Godoy J; Castillo A; Soto P; Mesa T Rev Neurol; 2013 Apr; 56(8):401-8. PubMed ID: 23568682 [TBL] [Abstract][Full Text] [Related]
34. Assessing the value of topiramate in refractory status epilepticus. Madžar D; Kuramatsu JB; Gerner ST; Huttner HB Seizure; 2016 May; 38():7-10. PubMed ID: 27039016 [TBL] [Abstract][Full Text] [Related]
35. Intravenous Corticosteroids as an Adjunctive Treatment for Refractory and Super-Refractory Status Epilepticus: An Observational Cohort Study. Pantazou V; Novy J; Rossetti AO CNS Drugs; 2019 Feb; 33(2):187-192. PubMed ID: 30627972 [TBL] [Abstract][Full Text] [Related]
36. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. Bellante F; Legros B; Depondt C; Créteur J; Taccone FS; Gaspard N J Neurol; 2016 Apr; 263(4):799-806. PubMed ID: 26914931 [TBL] [Abstract][Full Text] [Related]
37. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012 [TBL] [Abstract][Full Text] [Related]
38. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study. Kantanen AM; Sairanen J; Kälviäinen R Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204 [TBL] [Abstract][Full Text] [Related]
39. Ketamine use in the treatment of refractory status epilepticus. Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676 [TBL] [Abstract][Full Text] [Related]
40. Early-onset status epilepticus in patients with acute encephalitis. Sonneville R; Mariotte E; Neuville M; Minaud S; Magalhaes E; Ruckly S; Cantier M; Voiriot G; Radjou A; Smonig R; Soubirou JF; Mourvillier B; Bouadma L; Wolff M; Timsit JF Medicine (Baltimore); 2016 Jul; 95(30):e4092. PubMed ID: 27472682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]